To evaluate the Safety and efficacy of two Unani formulations in the treatment of Leucorrhoea
Phase 2
- Conditions
- Health Condition 1: null- Sailan-ur-Reham(Leucorrhoea)Health Condition 2: A599- Trichomoniasis, unspecifiedHealth Condition 3: A599- Trichomoniasis, unspecified
- Registration Number
- CTRI/2015/02/005562
- Lead Sponsor
- Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
•Female patients in the age group of 13-45 years.
•Patients having excessive white discharge with or without any of the following associated symptoms
ï?§Backache
ï?§General Weakness
ï?§Anaemia
Exclusion Criteria
•Patients having acute/acute on chronic/Chronic PIDs as per Hegards Criteria (Annexure-IV)
•Patients on long-term medications.
•Patients on Oral Contraceptives/IUDs.
•Patients taking hormonal therapy.
•Any abnormal condition on p/s Examination.
•Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptomsTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Hematological and biochemical assessments for safetyTimepoint: 4 weeks